SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Directorate Change

18 Mar 2015 07:00

RNS Number : 6993H
Caledonia Investments PLC
18 March 2015
Β 

ο»Ώ

Caledonia Investments plc

Β 

Announcement of board and committee changes

Β 

Β 

The Board of Caledonia Investments plc ("Caledonia" or the "Company") is pleased to announce the following changes to its board and committee membership.

Β 

David Stewart and Shonaid Jemmett-Page are appointed as independent non-executive directors, David with immediate effect and Shonaid with effect from 1 July 2015.

Β 

David began his career at Swire Pacific in 1981, working in various roles in Australia, Thailand, the Philippines and Hong Kong. In 1986 he moved into the financial sector, first to James Capel, where he set up and managed research and sales desks in London and Tokyo specialising in Asian derivatives products, and then in 1995 to Fidelity Investments, where he was head of its emerging markets funds and then president of its Institutional UK/EMEA business. In 2005, David joined Odey Asset Management as Chief Executive Officer, a position he held for eight years before moving to a non-executive director role from 2013 to 2014. David is currently Chairman and a co-founder of IMM Associates and a non-executive executive adviser to the board of Knight Frank.

Β 

David will join Caledonia's Audit, Nomination and Remuneration Committees.

Β 

Shonaid Jemmett-Page spent the first twenty years of her career at KPMG in London and Tokyo, rising to the position of Partner, Financial Services. In 2001, she moved to Unilever, where she was Senior Vice President, Finance and Information for Asia, based in Singapore, before returning to the UK as Finance Director for Unilever's global non-food business. In 2009, Shonaid joined CDC Group as Chief Operating Officer, a position she held until 2012. Since then, Shonaid has focussed on non-executive appointments and is currently a non-executive director and chair of the audit committee of GKN, APR Energy, Amlin, Origo Partners and Greencoat UK Wind. Within the past five years she has also held non-executive directorships of Havelock Europa and Close Brothers Group.

Β 

Shonaid will join Caledonia's Governance, Nomination and Remuneration Committees.

Β 

As announced in May of last year, Charles Allen-Jones had indicated a wish to step down from the board and he has retired with immediate effect. He is replaced as Senior Independent Non-Executive Director and Chairman of the Governance Committee by Charles Gregson, who will cease to be a member of the Audit Committee. Stuart Bridges is also appointed a member of the Governance Committee.

Β 

Commenting on the board changes, Rod Kent, Chairman of Caledonia, said:

Β 

"I am delighted that David Stewart and Shonaid Jemmett-Page have agreed to join Caledonia as independent non-executive directors. They both bring a wealth of experience in international business and investment, particularly in Asia and emerging markets, which will be of considerable benefit to our board.

Β 

I would also like to thank Charles Allen-Jones for the enormous contribution that he has made to the Company over the past 13 years, particularly as Senior Independent Director. His wise counsel will be greatly missed and we wish him well in his retirement."

Β 

Β 

Β 

Enquiries

Β 

Caledonia Investments plc

Rod Kent (Chairman)

Tel: +44 20 7802 8080

Β 

Tulchan Communications

Peter Hewer

Tel: +44 20 7353 4200

Β 

18 March 2015

Β 

There are no details relating to David Stewart or Shonaid Jemmett-Page which require disclosure under Listing Rule 9.6.13 (2) to (6).

Β 

In accordance with section 430 (2B) of the Companies Act 2006, Caledonia confirms that, other than fees payable to him up to the date of his retirement, no remuneration or payment has been or will be made in connection with Charles Allen-Jones ceasing to be a director of the Company.

Β 

Β 

END

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
BOAQDLFFEXFLBBB
Date   Source Headline
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 202610:30 amRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSFunds spotlight event
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 202611:36 amRNSDirector/PDMR Shareholding
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 202611:00 amRNSAppointment of non-executive director
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20263:00 pmRNSDirector/PDMR Shareholding
12th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSNet Asset Value(s)
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20251:36 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 202511:00 amRNSNet Asset Value(s)
3rd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTotal Voting Rights
28th Nov 20255:04 pmRNSDirector/PDMR Shareholding
28th Nov 20252:51 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 202512:42 pmRNSIrrevocable Share Repurchase Instruction
25th Nov 20257:00 amRNSHalf-year Financial Report
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSNotice of half-year results
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.